• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

介入肿瘤学最新进展

Interventional oncology update.

作者信息

Newbury Alex, Ferguson Chantal, Valero Daniel Alvarez, Kutcher-Diaz Roberto, McIntosh Lacey, Karamanian Ara, Harman Aaron

机构信息

UMass Memorial Medical Center, Worcester, MA, USA.

Prostate Laser Center, Houston, TX, USA.

出版信息

Eur J Radiol Open. 2022 Jun 20;9:100430. doi: 10.1016/j.ejro.2022.100430. eCollection 2022.

DOI:10.1016/j.ejro.2022.100430
PMID:35761853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9233207/
Abstract

Interventional Oncology (IO) is a subspecialty field of Interventional Radiology bridging between diagnostic radiology and the clinical oncology team, addressing the diagnosis and treatment of cancer. There have been many exciting advancements in the field of IO in recent years; far too many to cover in a single paper. To give each topic sufficient attention, we have limited the scope of this review article to four topics which we feel have the potential to drastically change how cancer is treated managed in the immediate future.

摘要

介入肿瘤学(IO)是介入放射学的一个亚专业领域,它架起了诊断放射学与临床肿瘤学团队之间的桥梁,负责癌症的诊断和治疗。近年来,介入肿瘤学领域取得了许多令人振奋的进展;多得无法在一篇论文中涵盖。为了对每个主题给予足够的关注,我们将这篇综述文章的范围限制在四个主题上,我们认为这四个主题有可能在不久的将来彻底改变癌症的治疗和管理方式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac43/9233207/a1f7385ddc4c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac43/9233207/b593cabfed22/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac43/9233207/18518f7fc4b6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac43/9233207/a1f7385ddc4c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac43/9233207/b593cabfed22/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac43/9233207/18518f7fc4b6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac43/9233207/a1f7385ddc4c/gr3.jpg

相似文献

1
Interventional oncology update.介入肿瘤学最新进展
Eur J Radiol Open. 2022 Jun 20;9:100430. doi: 10.1016/j.ejro.2022.100430. eCollection 2022.
2
Role of Machine Learning and Artificial Intelligence in Interventional Oncology.机器学习和人工智能在介入肿瘤学中的作用。
Curr Oncol Rep. 2021 Apr 20;23(6):70. doi: 10.1007/s11912-021-01054-6.
3
Technological Advancements in Interventional Oncology.介入肿瘤学的技术进展
Diagnostics (Basel). 2023 Jan 7;13(2):228. doi: 10.3390/diagnostics13020228.
4
Radiogenomics in Interventional Oncology.介入肿瘤学中的放射基因组学
Curr Oncol Rep. 2021 Jan 2;23(1):9. doi: 10.1007/s11912-020-00994-9.
5
Immuno-oncology and Its Opportunities for Interventional Radiologists: Immune Checkpoint Inhibition and Potential Synergies with Interventional Oncology Procedures.免疫肿瘤学及其对介入放射科医生的机遇:免疫检查点抑制以及与介入肿瘤学程序的潜在协同作用
J Vasc Interv Radiol. 2017 Nov;28(11):1487-1494. doi: 10.1016/j.jvir.2017.07.018. Epub 2017 Sep 12.
6
Immuno-oncology and interventional oncology: a winning combination. The latest scientific evidence.免疫肿瘤学和介入肿瘤学:强强联合。最新科学证据。
Eur Rev Med Pharmacol Sci. 2019 Jun;23(12):5343-5350. doi: 10.26355/eurrev_201906_18201.
7
Immunotherapy and the Interventional Oncologist: Challenges and Opportunities-A Society of Interventional Oncology White Paper.免疫治疗与介入肿瘤学家:挑战与机遇——介入肿瘤学会白皮书。
Radiology. 2019 Jul;292(1):25-34. doi: 10.1148/radiol.2019182326. Epub 2019 Apr 23.
8
Interventional oncology in children: Where are we now?
J Med Imaging Radiat Oncol. 2024 Jun 14. doi: 10.1111/1754-9485.13719.
9
Interventional oncology: the future.介入肿瘤学:未来。
Pediatr Radiol. 2011 May;41 Suppl 1:S201-6. doi: 10.1007/s00247-011-1990-x. Epub 2011 Apr 27.
10
Prime Time for Artificial Intelligence in Interventional Radiology.人工智能在介入放射学中的黄金时代。
Cardiovasc Intervent Radiol. 2022 Mar;45(3):283-289. doi: 10.1007/s00270-021-03044-4. Epub 2022 Jan 14.

引用本文的文献

1
AI and Interventional Radiology: A Narrative Review of Reviews on Opportunities, Challenges, and Future Directions.人工智能与介入放射学:关于机遇、挑战及未来方向的综述之叙述性综述
Diagnostics (Basel). 2025 Apr 1;15(7):893. doi: 10.3390/diagnostics15070893.
2
What's new in cancer and molecular imaging.癌症与分子成像的新进展。
Eur J Radiol Open. 2022 Aug 24;9:100437. doi: 10.1016/j.ejro.2022.100437. eCollection 2022.

本文引用的文献

1
Efficacy and Safety of Radiofrequency Ablation for Breast Cancer Smaller Than 2 cm: A Systematic Review and Meta-Analysis.2厘米以下乳腺癌射频消融术的疗效与安全性:一项系统评价与Meta分析
Front Oncol. 2021 May 3;11:651646. doi: 10.3389/fonc.2021.651646. eCollection 2021.
2
Thermal Ablation as an Alternative for Surgical Resection of Small (≤ 2 cm) Breast Cancers: A Meta-Analysis.热消融术作为小(≤ 2 厘米)乳腺癌手术切除的替代方法:一项荟萃分析。
Clin Breast Cancer. 2021 Dec;21(6):e715-e730. doi: 10.1016/j.clbc.2021.03.004. Epub 2021 Mar 17.
3
Cancer Statistics, 2021.
癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
4
Combination of thermally ablative focused ultrasound with gemcitabine controls breast cancer via adaptive immunity.热消融聚焦超声联合吉西他滨通过适应性免疫控制乳腺癌。
J Immunother Cancer. 2020 Aug;8(2). doi: 10.1136/jitc-2020-001008.
5
Development and clinical application of deep learning model for lung nodules screening on CT images.深度学习模型在 CT 图像肺结节筛查中的开发与临床应用。
Sci Rep. 2020 Aug 12;10(1):13657. doi: 10.1038/s41598-020-70629-3.
6
Safety and Effectiveness of Yttrium-90 Radioembolization around the Time of Immune Checkpoint Inhibitors for Unresectable Hepatic Metastases.免疫检查点抑制剂治疗不可切除肝转移瘤前后钇-90放射性栓塞的安全性和有效性
J Vasc Interv Radiol. 2020 Aug;31(8):1233-1241. doi: 10.1016/j.jvir.2020.04.029.
7
Predictors of Progression-Free Survival and Local Tumor Control after Percutaneous Thermal Ablation of Oligometastatic Breast Cancer: Retrospective Study.寡转移性乳腺癌经皮热消融术后无进展生存期和局部肿瘤控制的预测因素:回顾性研究
J Vasc Interv Radiol. 2020 Aug;31(8):1201-1209. doi: 10.1016/j.jvir.2020.02.016. Epub 2020 Jul 19.
8
Automatic needle tracking using Mask R-CNN for MRI-guided percutaneous interventions.基于 Mask R-CNN 的磁共振引导经皮介入自动穿刺针跟踪。
Int J Comput Assist Radiol Surg. 2020 Oct;15(10):1673-1684. doi: 10.1007/s11548-020-02226-8. Epub 2020 Jul 16.
9
Comparative Effectiveness of Radiotherapy versus Focal Laser Ablation in Patients with Low and Intermediate Risk Localized Prostate Cancer.低危和中危局限性前列腺癌患者放疗与局灶性激光消融的疗效比较。
Sci Rep. 2020 Jun 4;10(1):9112. doi: 10.1038/s41598-020-65863-8.
10
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.阿替利珠单抗联合贝伐珠单抗治疗不可切除肝细胞癌。
N Engl J Med. 2020 May 14;382(20):1894-1905. doi: 10.1056/NEJMoa1915745.